Kalb Michael Wayne
SEC-identified person · CIK 1678248 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Catalyst Pharmaceutical Partners, Inc. CPRX | Executive Vice President & CFO | filed 2024 - 2026 |
| IPI Legacy Liquidation Co IMPLQ | CFO | filed 2023 - 2023 |
| Cincor Pharma, Inc. CINC | EVP & Chief Financial Officer | filed 2022 - 2023 |
| Amarin Corp PLC\UK AMRN | SVP and CFO | filed 2016 - 2022 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.